PMVP PMV Pharmaceuticals, Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 14, 2026
$1.79
· % 处于52周区间
· 高于低点
· 至高点
$1.0252周低点
$1.9152周高点
市值 (MRQ)
$96M
P/E
-1.2
EPS
$-1.48
PMVP 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$1.79
市值 (MRQ)
$96M
P/E
-1.2
EPS
$-1.48
ROE
-63.4%
52周区间
$1–$2
PMVP 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
10年表现 收入、净利润、利润率和每股收益趋势
EPS$-1.482020-12-31 → 2025-12-31
自由现金流$-74M2020-12-31 → 2025-12-31
净利率-1226.8%2020-12-31 → 2025-12-31
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | PMVP | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E | -1.25年均值 ≈-5.6 | ≈-5.6 | · | · | |
| P/S | 15.15年均值 ≈495.9 | ≈495.9 | 73.7 | 低估 | |
| 市净率 (MRQ) | 1.35年均值 ≈1.4 | ≈1.4 | 2.5 | 低估 | |
| 股价/自由现金流 (TTM) | -1.35年均值 ≈-6.5 | ≈-6.5 | · | · | |
| 市现率 (TTM) | -1.35年均值 ≈-6.8 | ≈-6.8 | · | · | |
| Price / Tangible Book (市净率（有形资产）) | 0.95年均值 ≈1.4 | ≈1.4 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | PMVP | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Operating Margin (营业利润率) | -1360.4%5年均值 ≈-3597.3% | ≈-3597.3% | -3199.0% | 顶尖 | |
| EBITDA Margin (息税折旧摊销前利润率) | -1360.4%5年均值 ≈-3597.3% | ≈-3597.3% | -3199.0% | 顶尖 | |
| Pretax Margin (税前利润率) | -1261.1%5年均值 ≈-3496.1% | ≈-3496.1% | -2294.8% | 持平 | |
| Net Profit Margin (净利润率) | -1226.8%5年均值 ≈-3460.0% | ≈-3460.0% | -2452.9% | 持平 | |
| ROA | -50.5%5年均值 ≈-28.9% | ≈-28.9% | -57.6% | 持平 | |
| ROE | -63.4%5年均值 ≈-34.3% | ≈-34.3% | -63.4% | 持平 | |
| ROIC | -80.1%5年均值 ≈-40.8% | ≈-40.8% | -68.6% | 低于平均水平 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | PMVP | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 7.75年均值 ≈16.9 | ≈16.9 | 7.7 | 持平 | |
| Quick Ratio (速动比率) | 9.95年均值 ≈16.5 | ≈16.5 | 7.5 | 持平 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | PMVP | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | -40.5%5年均值 ≈167.9% | ≈167.9% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | 20.4%5年均值 ≈121.9% | ≈121.9% | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | 57.6% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | PMVP | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.05年均值 ≈0.0 | ≈0.0 | 0.0 | 顶尖 |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
9.8%
下次报告
十一月 10, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年6月30日 | 八月 14, 2026 | $-0.34 | $-0.40 | 14.0% |
| 2026年3月31日 | 五月 8, 2026 | $-0.34 | $-0.42 | 18.7% |
| 2025年12月31日 | $-0.34 | $-0.41 | 17.7% | |
| 2025年9月30日 | $-0.40 | $-0.41 | 2.6% | |
| 2025年6月30日 | $-0.41 | $-0.39 | -4.9% | |
| 2025年3月31日 | $-0.34 | $-0.38 | 11.0% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| R&D Expense | $70M | $59M | $56M | $52M | $36M | $24M | $21M | |
| SG&A Expense | $16M | $27M | $24M | $25M | $22M | $11M | $6M | |
| Operating Expenses | $86M | $85M | $80M | $77M | $58M | $35M | $27M | |
| Operating Income | $-86M | $-85M | $-80M | $-77M | $-58M | $-35M | $-27M | |
| Other Non-op | $6M | $11M | $11M | $4M | $470.0K | $508.0K | $1M | |
| Pretax Income | $-80M | $-75M | $-69M | $-73M | $-58M | $-34M | $-25M | |
| Income Tax | $-2M | $-16M | $2.0K | $-9.0K | $23.0K | $6.0K | $8.0K | |
| Net Income | $-78M | $-59M | $-69M | $-73M | $-58M | $-34M | $-25M | |
| EPS (Basic) | $-1.48 | $-1.14 | $-1.44 | $-1.61 | $-1.28 | $-2.40 | · | |
| EPS (Diluted) | $-1.48 | $-1.14 | $-1.44 | $-1.61 | $-1.28 | $-2.40 | · | |
| Shares (Basic) | 52,541,613 | 51,578,807 | 48,014,645 | 45,594,824 | 45,137,656 | 14,364,475 | · | |
| Shares (Diluted) | 52,541,613 | 51,578,807 | 48,014,645 | 45,594,824 | 45,137,656 | 14,364,475 | · | |
| EBITDA | $-86M | $-85M | $-80M | $-77M | $-58M | $-35M | · |
资产负债表
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $38M | $41M | $38M | $108M | $172M | $361M | $73M | |
| Short-term Investments | $75M | $129M | $165M | $133M | $125M | · | · | |
| Prepaid Expense | $2M | $6M | $4M | $5M | $3M | $3M | $607.0K | |
| Current Assets | $115M | $176M | $207M | $247M | $301M | $365M | $102M | |
| PP&E (Net) | $237.0K | $409.0K | $11M | $11M | $3M | $569.0K | $739.0K | |
| PP&E (Gross) | $2M | $2M | $14M | $13M | $5M | $2M | $2M | |
| Accum. Depreciation | $1M | $1M | $3M | $2M | $2M | $2M | $1M | |
| Other Non-current Assets | $297.0K | $235.0K | $190.0K | $313.0K | $221.0K | $201.0K | $201.0K | |
| Total Assets | $117M | $191M | $252M | $270M | $332M | $366M | $103M | |
| Accounts Payable | $3M | $7M | $3M | $3M | $3M | $2M | $3M | |
| Accrued Liabilities | $8M | $7M | $10M | $7M | $9M | $5M | $2M | |
| Current Liabilities | $11M | $14M | $14M | $11M | $12M | $6M | $5M | |
| Capital Leases | $435.0K | $838.0K | $12M | $13M | $11M | · | · | |
| Other Non-current Liabilities | · | · | · | · | · | · | $51.0K | |
| Total Liabilities | $12M | $15M | $26M | $24M | $23M | $6M | $5M | |
| Retained Earnings | $-446M | $-369M | $-310M | $-241M | $-168M | $-110M | $-75M | |
| AOCI | $84.0K | $139.0K | $224.0K | $-445.0K | $-78.0K | · | $-3.0K | |
| Stockholders' Equity | $105M | $176M | $226M | $246M | $309M | $359M | $-70M | |
| Liabilities + Equity | $117M | $191M | $252M | $270M | $332M | $366M | $103M | |
| Shares Outstanding | 53,331,766 | 51,935,134 | 51,445,862 | 45,771,332 | 45,433,684 | 44,777,818 | 3,046,200 |
现金流
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $6M | $9M | $12M | $10M | $5M | $2M | $908.0K | |
| Operating Cash Flow | $-74M | $-51M | $-56M | $-64M | $-47M | $-33M | $-22M | |
| CapEx | $29.0K | $655.0K | $962.0K | $8M | $1M | $148.0K | $109.0K | |
| Investing Cash Flow | $70M | $53M | $-51M | $-1M | $-144M | $28M | $3M | |
| Stock Issued | · | · | $35M | · | · | $223M | · | |
| Net Stock Activity | · | · | $35M | · | · | $223M | · | |
| Financing Cash Flow | $505.0K | $313.0K | $36M | $958.0K | $2M | $293M | $62M | |
| Net Change in Cash | $-3M | $2M | $-71M | $-64M | $-188M | $288M | $43M | |
| Taxes Paid | · | · | · | · | $23.0K | $6.0K | $8.0K | |
| Free Cash Flow | $-74M | $-52M | $-57M | $-72M | $-48M | $-33M | · |
盈利能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Operating Margin | -1360.4% | -802.0% | -717.3% | -2124.1% | -12982.8% | -5367.4% | · | |
| Net Margin | -1226.8% | -551.0% | -617.3% | -2021.4% | -12883.3% | -5290.3% | · | |
| Pretax Margin | -1261.1% | -702.1% | -617.3% | -2021.7% | -12878.2% | -5289.4% | · | |
| EBITDA Margin | -1360.4% | -802.0% | -717.3% | -2124.1% | -12982.8% | -5367.4% | · | |
| ROA | -50.5% | -26.5% | -26.4% | -24.4% | -16.6% | -14.7% | · | |
| ROE | -63.4% | -31.4% | -29.8% | -28.9% | -18.3% | -9.5% | · | |
| ROIC | -80.1% | -38.1% | -35.5% | -31.3% | -18.9% | -9.7% | · |
流动性与偿付能力
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.1 | 12.2 | 14.8 | 22.8 | 24.7 | 56.9 | · | |
| Quick Ratio | 9.9 | 11.8 | 14.5 | 22.3 | 24.3 | 56.4 | · |
效率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · |
每股
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.96 | $3.39 | $4.39 | $5.38 | $6.79 | $8.02 | · | |
| Revenue / Share | $0.12 | $0.21 | $0.23 | $0.08 | · | · | · | |
| Cash Flow / Share | $-1.40 | $-0.99 | $-1.16 | $-1.40 | · | · | · | |
| Cash / Share | $0.71 | $0.79 | $0.73 | $2.37 | $3.80 | $8.07 | · | |
| EPS (TTM) | $-1.48 | $-1.14 | $-1.44 | $-1.61 | $-1.28 | $-2.40 | · |
增长率
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -40.5% | -4.6% | 208.0% | 707.8% | -31.0% | · | · | |
| Revenue CAGR 3Y | 20.4% | 187.4% | 157.9% | · | · | · | · | |
| Revenue CAGR 5Y | 57.6% | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $6M | $11M | $11M | $4M | $449.0K | $651.0K | · | |
| Net Income TTM | $-78M | $-59M | $-69M | $-73M | $-58M | $-34M | · | |
| Market Cap | $67M | $78M | $159M | $398M | $1.05B | $2.75B | · | |
| P/E | -0.8 | -1.3 | -2.2 | -5.4 | -18.0 | -25.6 | · | |
| P/S | 10.5 | 7.4 | 14.3 | 109.8 | 2337.5 | 4230.9 | · | |
| P/B | 0.6 | 0.4 | 0.7 | 1.6 | 3.4 | 7.7 | · | |
| P / Tangible Book | 0.6 | 0.4 | 0.7 | 1.6 | 3.4 | 7.7 | · | |
| P / Cash Flow | -0.9 | -1.5 | -2.9 | -6.2 | -22.5 | -84.1 | · | |
| P / FCF | -0.9 | -1.5 | -2.8 | -5.6 | -21.9 | -83.7 | · | |
| Earnings Yield | -118.4% | -75.5% | -46.5% | -18.5% | -5.5% | -3.9% | · |
损益表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $15M | $15M | $16M | $18M | $18M | $17M | $14M | $17M | $15M | $13M | $14M | $14M | $15M | $14M | $11M | $12M | |
| SG&A Expense | $4M | $4M | $3M | $4M | $4M | $4M | $11M | $5M | $6M | $5M | $6M | $6M | $6M | $6M | $6M | $7M | |
| Operating Expenses | $19M | $19M | $19M | $23M | $23M | $22M | $25M | $22M | $20M | $18M | $20M | $20M | $21M | $19M | $18M | $19M | |
| Operating Income | $-19M | $-19M | $-19M | $-23M | $-23M | $-22M | $-25M | $-22M | $-20M | $-18M | $-20M | $-20M | $-21M | $-19M | $-18M | $-19M | |
| Other Non-op | $798.0K | $981.0K | $1M | $1M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $1M | $573.0K | $188.0K | |
| Pretax Income | $-18M | $-18M | $-18M | $-21M | $-21M | $-20M | $-23M | $-19M | $-17M | $-15M | $-17M | $-17M | $-19M | $-18M | $-17M | $-18M | |
| Income Tax | $3.0K | · | $26.0K | $-6.0K | $5.0K | $-2M | $0 | $74.0K | $-16M | · | $-1.0K | $4.0K | · | $-9.0K | $-2.0K | $2.0K | |
| Net Income | $-18M | $-18M | $-18M | $-21M | $-21M | $-17M | $-23M | $-19M | $-1M | $-15M | $-17M | $-17M | $-19M | $-18M | $-17M | $-18M | |
| EPS (Basic) | $-0.34 | $-0.34 | $-0.33 | $-0.40 | $-0.41 | $-0.34 | $-0.45 | $-0.37 | $-0.02 | $-0.30 | $-0.34 | $-0.38 | $-0.42 | $-0.40 | $-0.38 | $-0.41 | |
| EPS (Diluted) | $-0.34 | $-0.34 | $-0.33 | $-0.40 | $-0.41 | $-0.34 | $-0.45 | $-0.37 | $-0.02 | $-0.30 | $-0.34 | $-0.38 | $-0.42 | $-0.40 | $-0.38 | $-0.41 | |
| Shares (Basic) | 53,386,909 | 53,331,766 | · | 52,993,238 | 52,010,827 | 51,952,062 | · | 51,574,027 | 51,478,751 | 51,445,862 | 49,047,296 | 45,813,132 | 45,773,357 | 45,622,957 | 45,571,067 | 45,466,044 | |
| Shares (Diluted) | 53,386,909 | 53,331,766 | · | 52,993,238 | 52,010,827 | 51,952,062 | · | 51,574,027 | 51,478,751 | 51,445,862 | 49,047,296 | 45,813,132 | 45,773,357 | 45,622,957 | 45,571,067 | 45,466,044 | |
| EBITDA | $-19M | $-19M | · | $-23M | $-23M | $-22M | · | $-22M | $-20M | $-18M | $-20M | $-20M | $-21M | $-19M | $-18M | $-19M |
资产负债表
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $12M | $39M | $38M | $36M | $44M | $51M | $41M | $49M | $49M | $48M | $52M | $68M | $143M | $100M | $87M | $116M | |
| Short-term Investments | $67M | $54M | $75M | $93M | $98M | $109M | $129M | $134M | $164M | $150M | $150M | $119M | $86M | $159M | $190M | $167M | |
| Prepaid Expense | $2M | $2M | $2M | $3M | $3M | $3M | $6M | $6M | $5M | $4M | $3M | $3M | $3M | $5M | $4M | $4M | |
| Current Assets | $81M | $96M | $115M | $132M | $145M | $163M | $176M | $190M | $219M | $202M | $205M | $190M | $233M | $265M | $282M | $288M | |
| PP&E (Net) | $154.0K | $203.0K | $237.0K | $255.0K | $287.0K | $376.0K | $409.0K | $10M | $11M | $11M | $11M | $11M | $11M | $10M | $9M | $5M | |
| PP&E (Gross) | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $14M | $15M | $15M | $14M | $14M | $14M | $12M | $11M | $7M | |
| Accum. Depreciation | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $4M | $4M | $4M | $3M | $3M | $2M | $2M | $2M | $2M | |
| Other Non-current Assets | $296.0K | $296.0K | $297.0K | $249.0K | $248.0K | $237.0K | $235.0K | $242.0K | $182.0K | $182.0K | $180.0K | $181.0K | $314.0K | $307.0K | $308.0K | $221.0K | |
| Total Assets | $82M | $97M | $117M | $134M | $153M | $171M | $191M | $223M | $238M | $237M | $261M | $242M | $254M | $285M | $301M | $315M | |
| Accounts Payable | $2M | $2M | $3M | $3M | $3M | $4M | $7M | $2M | $5M | $859.0K | $2M | $3M | $2M | $5M | $3M | $5M | |
| Accrued Liabilities | $8M | $7M | $8M | $9M | $9M | $6M | $7M | $10M | $6M | $10M | $9M | $8M | $9M | $6M | $8M | $7M | |
| Current Liabilities | $11M | $9M | $11M | $12M | $12M | $10M | $14M | $14M | $11M | $12M | $11M | $11M | $11M | $12M | $11M | $12M | |
| Capital Leases | $0 | $0 | $435.0K | $541.0K | $643.0K | $742.0K | $838.0K | $12M | $12M | $12M | $13M | $13M | $13M | $12M | $12M | $11M | |
| Total Liabilities | $11M | $9M | $12M | $13M | $12M | $11M | $15M | $26M | $23M | $24M | $23M | $24M | $24M | $24M | $24M | $23M | |
| Retained Earnings | $-483M | $-464M | $-446M | $-428M | $-407M | $-386M | $-369M | $-346M | $-326M | $-325M | $-294M | $-278M | $-260M | $-222M | $-203M | $-186M | |
| AOCI | $-82.0K | $-15.0K | $84.0K | $91.0K | $21.0K | $84.0K | $139.0K | $410.0K | $-185.0K | $-129.0K | $-355.0K | $-328.0K | $-116.0K | $-1M | $-1M | $-666.0K | |
| Stockholders' Equity | $72M | $88M | $105M | $121M | $141M | $160M | $176M | $198M | $214M | $213M | $238M | $218M | $230M | $261M | $277M | $292M | |
| Liabilities + Equity | $82M | $97M | $117M | $134M | $153M | $171M | $191M | $223M | $238M | $237M | $261M | $242M | $254M | $285M | $301M | $315M | |
| Shares Outstanding | 53,460,432 | 53,331,766 | 53,331,766 | 52,993,238 | 52,993,238 | 51,954,135 | 51,935,134 | 51,749,504 | 51,522,125 | 51,445,862 | 51,157,636 | 46,143,536 | 45,774,761 | 45,624,860 | 45,622,610 | 45,532,392 |
现金流
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $2M | $1M | $1M | $1M | $2M | $2M | $1M | $2M | $3M | $3M | $3M | $3M | $3M | $2M | $3M | $2M | |
| Operating Cash Flow | $-15M | $-20M | $-17M | $-20M | $-18M | $-18M | $-17M | $-17M | $-2M | $-16M | $-16M | $-13M | $-15M | $-17M | $-14M | $-18M | |
| CapEx | $0 | $0 | $15.0K | $-1.0K | $11.0K | $4.0K | $56.0K | $1.0K | $4.0K | $594.0K | $44.0K | $565.0K | $156.0K | $2M | $4M | $796.0K | |
| Investing Cash Flow | $-12M | $21M | $18M | $12M | $11M | $29M | $8M | $17M | $2M | $26M | $-34M | $-64M | $50M | $30M | $-15M | $-39M | |
| Stock Issued | · | · | · | · | · | · | · | · | · | · | $33M | · | · | · | · | · | |
| Financing Cash Flow | $143.0K | $0 | $392.0K | $0 | $103.0K | $10.0K | $172.0K | $0 | $141.0K | $0 | $33M | $2M | $12.0K | $6.0K | $276.0K | $128.0K | |
| Net Change in Cash | $-27M | $1M | $2M | $-8M | $-7M | $10M | $-9M | $284.0K | $872.0K | $10M | $-16M | $-75M | $35M | $13M | $-29M | $-57M | |
| Taxes Paid | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $2.0K | |
| Free Cash Flow | · | $-20M | · | · | · | $-18M | · | · | · | $-17M | · | · | $-15M | · | · | $-19M |
盈利能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -2396.1% | -1940.7% | · | -1521.8% | -1353.8% | -1114.4% | · | -837.0% | -720.1% | -617.2% | -657.8% | -746.4% | -923.9% | -1723.8% | -2961.1% | -8130.6% | |
| Net Margin | -2295.2% | -1840.6% | · | -1422.9% | -1255.0% | -901.1% | · | -735.2% | -43.3% | -517.3% | -557.6% | -646.7% | -822.7% | -1621.8% | -2865.9% | -8049.3% | |
| Pretax Margin | -2294.8% | -1840.6% | · | -1423.3% | -1254.7% | -1014.6% | · | -732.4% | -620.7% | -517.3% | -557.6% | -646.6% | -822.7% | -1622.6% | -2866.2% | -8048.5% | |
| EBITDA Margin | -2396.1% | -1940.7% | · | -1521.8% | -1353.8% | -1114.4% | · | -837.0% | -720.1% | -617.2% | -657.8% | -746.4% | -923.9% | -1723.8% | -2961.1% | -8130.6% | |
| ROA | -15.4% | -13.5% | · | -11.8% | -10.9% | -8.6% | · | -7.9% | -0.51% | -5.5% | -6.5% | -6.4% | · | -5.8% | -5.3% | -5.5% | |
| ROE | -17.1% | -14.5% | · | -13.2% | -11.9% | -9.3% | · | -8.8% | -0.56% | -6.0% | -7.1% | -7.0% | · | -6.2% | -5.6% | -5.8% | |
| ROIC | -26.4% | · | · | -18.6% | -16.3% | -12.0% | · | -11.1% | -0.66% | · | · | -9.2% | · | -7.4% | -6.5% | -6.4% |
流动性与偿付能力
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.7 | 11.1 | · | 10.8 | 12.5 | 16.8 | · | 14.0 | 19.2 | 16.8 | 19.2 | 16.6 | · | 22.8 | 24.8 | 24.7 | |
| Quick Ratio | 7.5 | 10.9 | · | 10.5 | 12.3 | 16.4 | · | 13.5 | 18.7 | 16.4 | 18.8 | 16.3 | · | 22.2 | 24.4 | 24.2 |
效率
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 |
每股
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.34 | $1.65 | · | $2.28 | $2.65 | $3.08 | · | $3.82 | $4.16 | $4.13 | $4.64 | $4.72 | · | $5.72 | $6.07 | $6.41 | |
| Revenue / Share | $0.01 | $0.02 | · | $0.03 | $0.03 | $0.04 | · | $0.05 | $0.05 | $0.06 | $0.06 | $0.06 | $0.05 | $0.02 | · | · | |
| Cash Flow / Share | · | $-0.37 | · | · | · | $-0.35 | · | · | · | $-0.31 | · | · | $-0.33 | · | · | · | |
| Cash / Share | $0.23 | $0.73 | · | $0.69 | $0.83 | $0.99 | · | $0.94 | $0.94 | $0.93 | $1.02 | $1.48 | · | $2.19 | $1.91 | $2.54 | |
| EPS (TTM) | $-1.41 | $-1.48 | · | $-1.60 | $-1.57 | $-1.18 | · | $-0.99 | $-0.96 | $-1.32 | $-1.56 | $-1.62 | $-1.62 | $-1.59 | $-1.52 | · |
估值 (TTM)
| 指标 | 趋势 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4M | $5M | · | $7M | $9M | $10M | · | $12M | $12M | $12M | $10M | $8M | $6M | $2M | $1M | $550.0K | |
| Net Income TTM | $-75M | $-78M | · | $-83M | $-81M | $-61M | · | $-51M | $-49M | $-65M | $-73M | $-74M | $-74M | $-72M | $-69M | $-65M | |
| Market Cap | $72M | $66M | · | $74M | $56M | $57M | · | $77M | $83M | $87M | $314M | $289M | · | $543M | $650M | $948M | |
| P/E | -1.0 | -0.8 | · | -0.9 | -0.7 | -0.9 | · | -1.5 | -1.7 | -1.3 | -3.9 | -3.9 | -2.9 | -7.5 | -9.4 | · | |
| P/S | 16.0 | 12.3 | · | 10.0 | 6.6 | 5.9 | · | 6.7 | 7.0 | 7.4 | 32.5 | 37.0 | · | 263.2 | 624.5 | 1723.6 | |
| P/B | 1.0 | 0.8 | · | 0.6 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | 1.3 | 1.3 | · | 2.1 | 2.3 | 3.2 | |
| P / Tangible Book | 1.0 | 0.8 | · | 0.6 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.4 | 1.3 | 1.3 | · | 2.1 | 2.3 | 3.2 | |
| P / Cash Flow | · | -3.4 | · | · | · | -3.1 | · | · | · | -5.4 | · | · | · | · | · | -52.7 | |
| Earnings Yield | -105.2% | -119.3% | · | -114.3% | -148.1% | -108.3% | · | -66.4% | -59.3% | -77.6% | -25.4% | -25.9% | -34.0% | -13.4% | -10.7% | · |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 营业利润率 % | -1360.4% | -802.0% | -717.3% | -2124.1% | -12982.8% |
| 净收入 | $-78M | $-59M | $-69M | $-73M | $-58M |
| 稀释后每股收益 (EPS) | $-1.48 | $-1.14 | $-1.44 | $-1.61 | $-1.28 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 流动比率 | 10.1 | 12.2 | 14.8 | 22.8 | 24.7 |
| 速动比率 | 9.9 | 11.8 | 14.5 | 22.3 | 24.3 |
| 指标 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| 自由现金流 | $-74M | $-52M | $-57M | $-72M | $-48M |
机构持有人 (13F) 69 家申报者 · $47.1M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
69
持有价值
$47.1M
新仓位
5
已退出持仓
8
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 5 (-11 与上一季度对比) | 8 (0 与上一季度对比) | 15 (-2 与上一季度对比) | 22 (+4 与上一季度对比) | -2.5M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| BML Capital Management, LLC | $7142200 | 5330000 | 15.18% | 股份 |
| TANG CAPITAL MANAGEMENT LLC | $5688414 | 4245085 | 12.09% | 股份 |
| Sio Capital Management, LLC | $3529744 | 2634137 | 7.50% | 股份 |
| Euclidean Capital LLC | $3521042 | 2627643 | 7.48% | 股份 |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | $3162400 | 2360000 | 6.72% | 股份 |
| VANGUARD GROUP INC | $2712888 | 2170310 | 5.77% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $2696107 | 2012020 | 5.73% | 股份 |
| ArrowMark Colorado Holdings LLC | $2625836 | 1959579 | 5.58% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $2618542 | 1954136 | 5.56% | 股份 |
| Eversept Partners, LP | $2533811 | 1890904 | 5.38% | 股份 |
| BlackRock, Inc. | $1232556 | 919818 | 2.62% | 股份 |
| TWO SIGMA ADVISERS, LP | $1092625 | 874100 | 2.32% | 股份 |
| Stonepine Capital Management, LLC | $718355 | 536086 | 1.53% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $634624 | 473158 | 1.35% | 股份 |
| Aldebaran Capital, LLC | $626359 | 467432 | 1.33% | 股份 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $574663 | 428853 | 1.22% | 股份 |
| BIT Capital GmbH | $546124 | 407555 | 1.16% | 股份 |
| Verdad Advisers, LP | $485564 | 362361 | 1.03% | 股份 |
| Walleye Capital LLC | $449830 | 335694 | 0.96% | 股份 |
| Assenagon Asset Management S.A. | $442204 | 330003 | 0.94% | 股份 |
| MARSHALL WACE, LLP | $430956 | 321610 | 0.92% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $341399 | 254775 | 0.73% | 股份 |
| BANK OF AMERICA CORP /DE/ | $321747 | 240110 | 0.68% | 股份 |
| CITADEL ADVISORS LLC | $271082 | 202300 | 0.58% | 买入期权 |
| ADAR1 Capital Management, LLC | $269351 | 201008 | 0.57% | 股份 |
| STATE STREET CORP | $245459 | 183178 | 0.52% | 股份 |
| RBF Capital, LLC | $217348 | 162200 | 0.46% | 股份 |
| GOLDMAN SACHS GROUP INC | $183572 | 136994 | 0.39% | 股份 |
| MAI Capital Management | $178383 | 133122 | 0.38% | 股份 |
| Rangeley Capital, LLC | $132982 | 99240 | 0.28% | 股份 |
| NORTHERN TRUST CORP | $124683 | 93047 | 0.26% | 股份 |
| Ikarian Capital, LLC | $119442 | 89136 | 0.25% | 股份 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $94475 | 70504 | 0.20% | 股份 |
| PNC Financial Services Group, Inc. | $91038 | 67938 | 0.19% | 股份 |
| Quadrature Capital Ltd | $83174 | 62070 | 0.18% | 股份 |
| Seven Fleet Capital Management LP | $71782 | 53569 | 0.15% | 股份 |
| CITADEL ADVISORS LLC | $63393 | 47308 | 0.13% | 股份 |
| Accurate Wealth Management, LLC | $62000 | 50000 | 0.13% | 股份 |
| Cubist Systematic Strategies, LLC | $61417 | 43869 | 0.13% | 股份 |
| MORGAN STANLEY | $55856 | 41684 | 0.12% | 股份 |
| JANE STREET GROUP, LLC | $53878 | 40207 | 0.11% | 股份 |
| ALGERT GLOBAL LLC | $53403 | 39853 | 0.11% | 股份 |
| COOPER/HAIMS ADVISORS, LLC | $52288 | 39021 | 0.11% | 股份 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $50292 | 37531 | 0.11% | 股份 |
| Connor, Clark & Lunn Investment Management Ltd. | $43496 | 32460 | 0.09% | 股份 |
| Squarepoint Ops LLC | $42656 | 31833 | 0.09% | 股份 |
| HSBC HOLDINGS PLC | $40776 | 30891 | 0.09% | 股份 |
| BARCLAYS PLC | $37201 | 27761 | 0.08% | 股份 |
| BOOTHBAY FUND MANAGEMENT, LLC | $36349 | 27126 | 0.08% | 股份 |
| Vanguard Global Advisers, LLC | $28889 | 21559 | 0.06% | 股份 |
激进投资者及 5%+ 股东 1 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC, ORBIMED CAPITAL GP V LLC ×5 申报 | 2026年3月4日 | 0.00% | 修订 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 16 位内幕人士 · 5 位高管 · 9 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Michael Carulli | Chief Financial Officer | 2026年3月5日 A | 60146 | 0 | 0 | $0 |
| Winston Kung | COO, CFO | 2023年5月12日 A | 10600 | 0 | 0 | $0 |
| Robert Ticktin | General Counsel & COO | 2026年3月5日 A | 98695 | 0 | 0 | $0 |
| Deepika Jalota | Chief Development Officer | 2026年3月5日 A | 89959 | 0 | 0 | $0 |
| Leila Alland | Chief Medical Officer | 2023年9月15日 S | 45909 | 0 | 0 | $0 |
| Kirsten Flowers | 董事 | 2026年6月4日 A | · | 0 | 0 | $0 |
| Laurie Stelzer | 董事 | 2026年6月4日 A | · | 0 | 0 | $0 |
| Charles M Baum | 董事 | 2026年6月4日 A | · | 0 | 0 | $0 |
| Carol Giltner Gallagher | 董事 | 2026年6月4日 G | · | 0 | 0 | $0 |
| Arnold J Levine | 董事 | 2026年6月4日 A | 409842 | 0 | 0 | $0 |
| Richard A. Heyman | 董事 | 2025年6月5日 A | 0 | 0 | 0 | $0 |
| Peter A. Thompson | 董事 | 2022年6月2日 A | 475000 | 0 | 0 | $0 |
| Thilo Schroeder | 董事 | 2021年10月6日 S | 1101283 | 0 | 0 | $0 |
| Arnold L Oronsky | 董事 | 2020年9月29日 C | 6469911 | 0 | 0 | $0 |
| David Henry Mack | · | 2026年3月5日 A | 451109 | 0 | 0 | $0 |
| Wellington Biomedical Innovation Master Investors (Cayman) I L.P. | · | 2020年9月29日 C | 760267 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 3 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
PMVP 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 12 位分析师
买入
中位数目标
$4.00
+123.5%
4 33.3%
强烈买入
7 58.3%
买入
1 8.3%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
5 位分析师 · 2026-09-29平均目标 $4.20 +134.6%
← 低于所有目标
当前价格 $1.79
最低$3.00
平均值$4.20
最高$5.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| PMVP | $67M | -0.8 | -40.5% | -1226.8% | -63.4% | · |
| ABOS | $128M | -1.1 | · | · | -129.4% | · |
| HUMA | · | · | · | · | · | · |
| KRRO | $75M | -0.6 | 181.5% | -1834.5% | -140.8% | · |
| OTLK | $57M | -0.6 | · | -4416.2% | 193.1% | 4.0% |
| RNA | $10.91B | -14.5 | 72.1% | -3650.4% | -47.5% | · |
| CRBU | $151M | -1.0 | 11.7% | -1327.4% | -102.8% | · |
| SPRB | $120M | -1.7 | -51.3% | · | -139.9% | · |
| CBUS | · | -0.6 | -14.6% | -3492.3% | -223.0% | · |
| TNYA | $154M | -1.2 | · | · | -81.2% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-Q 于 八月 14, 2026 申报